In:
Cancer, Wiley, Vol. 129, No. 5 ( 2023-03), p. 728-739
Abstract:
The impact of S‐1 adjuvant chemotherapy for a longer period than the standard duration (6 months) on postoperative survival was investigated in patients who had resected pancreatic ductal adenocarcinoma based on a nationwide survey that collected real‐world data. The results demonstrated that the extension of S‐1 adjuvant chemotherapy beyond 6 months had no significant additional effect on survival.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
Language:
English
Publisher:
Wiley
Publication Date:
2023
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1